Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erik Thunström

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Journal of Clinical Medicine|December 18, 2020
Effect of Obstructive Sleep Apnea and CPAP Treatment on Cardiovascular Outcomes in Acute Coronary Syndrome in the RICCADSA TrialYüksel Peker, Erik Thunström, Helena Glantz, et al.
Sleep Medicine|April 6, 2025
Baseline lipid profile is associated with adverse outcomes in adults with coronary artery disease and obstructive sleep apnea despite lipid-lowering drugs and CPAP treatment: A secondary analysis of the RICCADSA cohortYeliz Celik, Baran Balcan, Erik Thunström, et al.
Sleep Medicine|June 6, 2026
CPAP therapy may improve HFpEF-like features in coronary artery disease with obstructive sleep apnea: A randomized controlled trialAylin Pihtili, Helena Glantz, Erik Thunström, et al.
International Journal of Cardiology|March 27, 2017
Answer to Dr. EyubogluSilvana Kontogeorgos, Erik Thunström, Magnus Johansson, et al.
Sleep Medicine|April 24, 2026
Weight reduction drives improvement in insulin resistance independent of OSA phenotype and CPAP treatment in the RICCADSA cohortAylin Pihtili, Yeliz Celik, Erik Thunström, et al.
Clinical Cardiology|June 29, 2026
Heart Failure With Preserved Ejection Fraction-Like Phenotype in Coronary Artery Disease and Obstructive Sleep Apnea: Insights From the RICCADSA CohortErik Thunström, Helena Glantz, Aylin Pihtili, et al.
American Journal of Respiratory and Critical Care Medicine|September 29, 2015
Blood Pressure Response to Losartan and Continuous Positive Airway Pressure in Hypertension and Obstructive Sleep ApneaErik Thunström, Karin Manhem, Annika Rosengren, et al.
International Journal of Cardiology|January 20, 2017
Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective studySilvana Kontogeorgos, Erik Thunström, Magnus C Johansson, et al.
Sleep Medicine|December 20, 2020
Continuous positive airway pressure treatment and anxiety in adults with coronary artery disease and nonsleepy obstructive sleep apnea in the RICCADSA trialYeliz Celik, Erik Thunström, Patrick J Strollo, et al.
Journal of Sleep Research|January 11, 2019
Determinants of depressive mood in coronary artery disease patients with obstructive sleep apnea and response to continuous positive airway pressure treatment in non-sleepy and sleepy phenotypes in the RICCADSA cohortBaran Balcan, Erik Thunström, Patrick J Strollo, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Journal of Clinical Medicine|December 18, 2020
Effect of Obstructive Sleep Apnea and CPAP Treatment on Cardiovascular Outcomes in Acute Coronary Syndrome in the RICCADSA TrialYüksel Peker, Erik Thunström, Helena Glantz, et al.
Sleep Medicine|April 6, 2025
Baseline lipid profile is associated with adverse outcomes in adults with coronary artery disease and obstructive sleep apnea despite lipid-lowering drugs and CPAP treatment: A secondary analysis of the RICCADSA cohortYeliz Celik, Baran Balcan, Erik Thunström, et al.
Sleep Medicine|June 6, 2026
CPAP therapy may improve HFpEF-like features in coronary artery disease with obstructive sleep apnea: A randomized controlled trialAylin Pihtili, Helena Glantz, Erik Thunström, et al.
International Journal of Cardiology|March 27, 2017
Answer to Dr. EyubogluSilvana Kontogeorgos, Erik Thunström, Magnus Johansson, et al.
Sleep Medicine|April 24, 2026
Weight reduction drives improvement in insulin resistance independent of OSA phenotype and CPAP treatment in the RICCADSA cohortAylin Pihtili, Yeliz Celik, Erik Thunström, et al.
Clinical Cardiology|June 29, 2026
Heart Failure With Preserved Ejection Fraction-Like Phenotype in Coronary Artery Disease and Obstructive Sleep Apnea: Insights From the RICCADSA CohortErik Thunström, Helena Glantz, Aylin Pihtili, et al.
American Journal of Respiratory and Critical Care Medicine|September 29, 2015
Blood Pressure Response to Losartan and Continuous Positive Airway Pressure in Hypertension and Obstructive Sleep ApneaErik Thunström, Karin Manhem, Annika Rosengren, et al.
International Journal of Cardiology|January 20, 2017
Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective studySilvana Kontogeorgos, Erik Thunström, Magnus C Johansson, et al.
Sleep Medicine|December 20, 2020
Continuous positive airway pressure treatment and anxiety in adults with coronary artery disease and nonsleepy obstructive sleep apnea in the RICCADSA trialYeliz Celik, Erik Thunström, Patrick J Strollo, et al.
Journal of Sleep Research|January 11, 2019
Determinants of depressive mood in coronary artery disease patients with obstructive sleep apnea and response to continuous positive airway pressure treatment in non-sleepy and sleepy phenotypes in the RICCADSA cohortBaran Balcan, Erik Thunström, Patrick J Strollo, et al.
Pageof 8